$ALXN Alexion Pharmaceuticals (NASDAQ:ALXN): Non-GAAP EPS of $2.79 beats by $0.31; GAAP EPS of $2.08 beats by $0.13. Revenue of $1.26B (+22.3% Y/Y) beats by $20M.